27.08.2013 Views

Electrostatic Similarity

Electrostatic Similarity

Electrostatic Similarity

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Electrostatic</strong> <strong>Similarity</strong><br />

Anthony Nicholls<br />

Cup VII, Santa Fe, March 7 th 2006


Outline<br />

• Introduction to EON<br />

• EON Joy<br />

• EON Despair<br />

• What EON is and isn’t<br />

• Mutant EONs<br />

• Fast EON. No, really.<br />

• The Meaning of EON


Shape & <strong>Electrostatic</strong>s<br />

m<br />

field<br />

potential<br />

n<br />

field<br />

steric<br />

dv<br />

dv<br />

m<br />

n<br />

=<br />

=<br />

!<br />

=<br />

"<br />

!<br />

=<br />

#<br />

$<br />

$<br />

%<br />

&<br />

%<br />

%<br />

&<br />

&<br />

space<br />

all<br />

2<br />

2<br />

1<br />

2<br />

space<br />

all<br />

2<br />

2<br />

1<br />

2<br />

)<br />

(<br />

)<br />

(<br />

ance<br />

Dist<br />

tic<br />

Electrosta<br />

Shape<br />

/<br />

, =<br />

!<br />

"<br />

ROCS<br />

EON


Shape/<strong>Electrostatic</strong> Tanimoto<br />

Overlap(<br />

A,<br />

B)<br />

Overlap(<br />

A,<br />

A)<br />

+ Overlap(<br />

B,<br />

B)<br />

! Overlap(<br />

A,<br />

B)<br />

• Larger Tanimoto = More similar = Better<br />

• Smaller Tanimoto = Less similar = Worse<br />

• Range= [0,1]<br />

• Value understood, e.g. ST>0.75 = similar shape


<strong>Electrostatic</strong> Tanimoto<br />

ET>0.6


• We Believe Steve<br />

• SAESAR:<br />

– COX2, Dopamine<br />

• Charged Ligands<br />

– PT1B kinase<br />

EON Joy<br />

– Thymidine Synthetase<br />

• BioIsosteres


Schnecke & Boström, 2006<br />

Cilomilast vs. Piclamilast


Steve Muchmore and the How Not to Get Published<br />

ST=0.84<br />

ET=0.56<br />

CT=<br />

HTS<br />

6nM<br />

3M V-HTS<br />

2-Step Synthesis<br />

2nM<br />

ROCS+EON


Shape Tanimoto<br />

0.2 0.4 0.6 0.8<br />

Decoys plus Highly Actives<br />

Shape and <strong>Electrostatic</strong> Tanimoto Similarities to Cox Crystal Ligand<br />

-0.2 0.0 0.2 0.4 0.6<br />

<strong>Electrostatic</strong> Tanimoto<br />

Wombat Decoys<br />

43 highly active<br />

Xray structure Cox2: SC-558


Shape Tanimoto<br />

0.0 0.2 0.4 0.6 0.8 1.0<br />

Dopamine D2 Cluster 1 Centroid vs Highly Actives and Wombat Decoys<br />

3 active structures<br />

ET<br />

Dopamine Active<br />

Wombat Decoys<br />

Centroid<br />

-0.2 0.0 0.2 0.4 0.6 0.8 1.0


Two Thrombin Inhibitors:<br />

Shape Tanimoto 0.51


Two Thrombin Inhibitors:<br />

<strong>Electrostatic</strong> Tanimoto 0.92


BioIsosteres


EON DESPAIR<br />

• Enrichment in Virtual Screening<br />

• Comparing molecules of different charge<br />

• It’s SO slow (That’s why it’s called EON!)


EON Despair


EON Downright Despondent


• A Miracle worker<br />

• Pharmacophores<br />

• “Cressett”<br />

What EON Isn’t


H<br />

Ligand Tautomers/pKa<br />

H<br />

H


Why single structure-EON might fail:2<br />

Ligand 1<br />

Protein


Why single structure-EON might fail:2<br />

Ligand 2<br />

Protein


Potential distribution mismatch<br />

Ligand 1<br />

Ligand 2


Why single structure-EON might fail:3<br />

Suppressed by


Why single structure-EON might fail:3<br />

Suppression<br />

removed


Why single structure-EON might fail:3<br />

Ligand 1<br />

Protein<br />

Suppression<br />

reinforced


Why single structure-EON might fail:4<br />

“mobile hydrogens”- Serine, Tyrosine<br />

H<br />

Ligand 1<br />

Protein


Why single structure-EON might fail:4<br />

H<br />

Ligand 2<br />

Protein


Natural Failures<br />

• Ligand Tautomer/pKa<br />

• Through-space effects<br />

– Alternate interaction sites<br />

• Charge suppression<br />

– Protein pKa variation<br />

• Rotatable protons<br />

– SER, TYR


EON vs. Pharmacophores<br />

• Single pharmacophore model has exactly the same<br />

issues<br />

• Multiple models-<br />

– Weighting of pharmacophores<br />

• Single pharmacophore model<br />

– Partial matches


EON is not Cresset<br />

• Cresset use fields to<br />

find pharmacophores<br />

• Requires very good<br />

charges (QM level)<br />

• Alignment is point<br />

based/ clique detect<br />

• Probably good (and<br />

faster) for screening<br />

• In EON the field is the<br />

pharmacophore<br />

• Seems to work with<br />

force-field level charges<br />

• Alignment is volumebased/<br />

ROCS-based<br />

• Care and attention when<br />

used for screening.<br />

Shape and color the<br />

appropriate comparison


Multiple Shape Models<br />

Shape Set 1<br />

Shape Set 3<br />

Shape Set 2


Multiple Shape and <strong>Electrostatic</strong><br />

Shape Set 1<br />

Models<br />

Shape & Electro Set 1<br />

Shape & Electro Set 2<br />

Shape & Electro Set 3


Example of Good EON


EON: Database searching, DHFR<br />

• Pre-screen w/ROCS<br />

– S.T. > 0.75<br />

– 8100 -> 315 hits<br />

• Rank by E.T.


2dsim = 0.58<br />

Great Lead Hop<br />

Rank(ST) = 173/315<br />

Rank(ET) = 34/315


EON Happiness<br />

• First find good shapes<br />

• Rerank within good shapes<br />

• Pareto ranking/ harmonic averaging<br />

• Don’t expect great ‘enrichment’<br />

– <strong>Electrostatic</strong> information degrades rapidly with shape<br />

mismatch


Charged Molecules & EON<br />

• The overlap of monopole fields is not formally<br />

convergent!<br />

• Distant Monopoles dominate Local Dipoles


Convergence<br />

[ ]<br />

!<br />

"<br />

"<br />

"<br />

"<br />

#<br />

#<br />

#<br />

###<br />

###<br />

dr<br />

dr<br />

r<br />

r<br />

r<br />

then<br />

r<br />

r<br />

if<br />

dr<br />

r<br />

r<br />

r<br />

d<br />

drd<br />

r<br />

r<br />

r<br />

dxdydz<br />

r<br />

r<br />

2<br />

2<br />

1<br />

2<br />

,<br />

1<br />

2<br />

2<br />

1<br />

2<br />

2<br />

1<br />

2<br />

1<br />

)<br />

(<br />

)<br />

(<br />

1<br />

)<br />

(<br />

)<br />

(<br />

)<br />

(<br />

)<br />

sin(<br />

)<br />

(<br />

)<br />

(<br />

)<br />

(<br />

)<br />

(<br />

$<br />

$<br />

$<br />

$<br />

$<br />

%<br />

&<br />

&<br />

$<br />

$<br />

$<br />

$<br />

L<br />

K<br />

1<br />

/<br />

0<br />

)<br />

,<br />

(<br />

)<br />

,<br />

(<br />

)<br />

,<br />

(<br />

)<br />

,<br />

(<br />

!<br />

"<br />

+ B<br />

A<br />

Overlap<br />

B<br />

B<br />

Overlap<br />

A<br />

A<br />

Overlap<br />

B<br />

A<br />

Overlap


Solvent Boundary Effect:<br />

Charge-Charged, Charged-Neutral, Neutral-Neutral<br />

1<br />

0.9<br />

0.8<br />

0.7<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.2<br />

0.1<br />

0<br />

5 10 15 20 25 30<br />

crg-crg1<br />

crg-crg2<br />

crg-neu1<br />

crg-neu2<br />

neu-neu1<br />

neu-neu2


Neutral<br />

Thermolysin Inhibitors<br />

Charged


ET(-2)<br />

0.52<br />

0.53<br />

0.54<br />

0.02<br />

0.01<br />

-0.26<br />

0.03<br />

Thermolysin Ligands: H 2 0<br />

ET(-1)<br />

0.64<br />

0.54<br />

0.76<br />

0.11<br />

0.06<br />

-0.30<br />

0.10


650 <strong>Electrostatic</strong> Tanimotos:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1<br />

-0.2<br />

Uncharged<br />

Mind The Gap!<br />

Charged


Potential Improvements<br />

• Scaled Tanimotos<br />

• Vector (E) Tanimoto<br />

• “You could say the magic ingredient is..”<br />

– (Marge Simpson, “The Simpsons: Lisa the Vegetarian”,<br />

15 th October, 1995)


Scaled Tanimoto


650 Scaled <strong>Electrostatic</strong> Tanimotos:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2<br />

y = 2.4025x + 0.0026<br />

R 2 = 0.9808<br />

y = 1.0005x - 0.0001<br />

R 2 = 1<br />

-0.2 0 0.2 0.4 0.6 0.8 1


650 Scaled <strong>Electrostatic</strong> Tanimotos:<br />

Neutral Target, Charged + Neutral Queries<br />

Scaled <strong>Electrostatic</strong> Tanimoto<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

Charged<br />

Unscaled <strong>Electrostatic</strong> Tanimoto


Vector Field Tanimotos<br />

• Monopoles die off as 1/r 2 , (Dipoles as 1/r 3 )<br />

– Don’t dominate long range<br />

– Formally convergent overlap functions<br />

• More variation between molecules<br />

– Lower Tanimotos


0.35<br />

0.3<br />

0.25<br />

0.2<br />

0.15<br />

0.1<br />

0.05<br />

-0.05<br />

-0.1<br />

-0.15<br />

-0.2<br />

Solvent Boundary Effect:<br />

Vector Field Tanimoto<br />

0<br />

0 5 10 15 20 25 30 35<br />

crg-crg1<br />

crg-crg2<br />

crg-neu1<br />

crg-neu2<br />

neu-neu1<br />

neu-neu2


650 Field <strong>Electrostatic</strong> Tanimotos:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

Uncharged<br />

Charged


650 Field <strong>Electrostatic</strong> Tanimotos:<br />

Neutral Target, Charged + Neutral Queries<br />

Field Tanimoto<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2<br />

y = 0.4139x + 0.029<br />

R 2 = 0.8629<br />

-0.4 -0.2 0 0.2 0.4 0.6 0.8 1<br />

Potential Tanimoto


The extra ingredient is..<br />

• The ‘B’ in ‘PB’<br />

..Salt!<br />

• Models mobile ions as a continuum<br />

• Linear & Non-Linear versions<br />

• Mimic mobile charges in active sites?


650 <strong>Electrostatic</strong> Tanimotos+80mM Salt:<br />

Neutral Target, Charged + Neutral Queries<br />

Salted <strong>Electrostatic</strong> Tanimoto<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2<br />

y = 0.6302x + 0.0241<br />

R 2 = 0.9477<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

<strong>Electrostatic</strong> Tanimoto


650 <strong>Electrostatic</strong> Tanimotos+80mM Salt:<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2


650 Salt <strong>Electrostatic</strong> Tanimotos<br />

Charged Target, Charged + Neutral Queries<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

40mM<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

80mM<br />

1<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

0<br />

-0.2 0 0.2 0.4 0.6 0.8 1<br />

-0.2<br />

120mM


Effects of Salt on Potentials:<br />

Differential Charge Placement, +1/-1 kT contours<br />

Formal<br />

charge<br />

No<br />

Salt<br />

ET=0.68<br />

0.04mM 30mM 0.08mM<br />

90mM<br />

ET=0.29 ET=0.22<br />

ET=0.029 ET=0.05


ET(-2)<br />

0.17<br />

0.16<br />

0.21<br />

0.14<br />

0.08<br />

-0.15<br />

0.13<br />

Thermolysin Ligands: Brine<br />

ET(-1)<br />

0.15<br />

0.02<br />

0.32<br />

0.32<br />

0.18<br />

-0.18<br />

0.26


Schnecke & Boström, 2006<br />

Cilomilast vs. Piclamilast


Saving Boström!<br />

ET=0.02<br />

ET=0.11


Are Active Sites Salty?<br />

• Dielectrics are about reorientation of<br />

dipoles<br />

• Ionic environments are about the migration<br />

of charges, e.g. protons.<br />

• I.e. maybe we are supposed to be using salt<br />

in EON comparisons!


EON: definition<br />

Conclusions<br />

1. An immeasurably long period of time<br />

2. A divine power or nature emanating from the<br />

Supreme Being and playing various roles in<br />

the operation of the universe

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!